First Page | Meta Content | |
---|---|---|
Document Date: 2012-01-20 16:54:18Open Document File Size: 112,79 KBShare Result on FacebookCitySan Francisco / Washington DC / Pharmacy / /CompanyHuman Retrovirology / Immune Deficiency Syndromes / National Academy Press / /CountryUnited States / /CurrencyUSD / /FacilityUniversity of California / Institute of Medicine / /IndustryTermHIV treatment / AIDS treatment / HIV prevention / HIV prevention program / HIV Care / AIDS Prevention / Hepatitis C treatment / /MedicalConditionHIV infection / total lifetime hepatitis C / HIV / transfusion-related infection / hepatitis C / viral infections / AIDS / Infectious Diseases / HIV/AIDS / infection / Hepatitis / infections / drug-related infection / /MedicalTreatmentAntiretroviral Therapy / /OrganizationU.S. Congress / National Academy of Science / Trust for America / Institute of Medicine / Australian government / office of Technology Policy Assessment / University of California / San Francisco / US Government Printing Office / Centers for Disease Control and Prevention / /Productzidovudine / /ProgrammingLanguagephp / R / /ProvinceOrStateCalifornia / /PublishedMediumJournal of Acquired Immune Deficiency Syndromes / /URLhttp /SocialTag |